These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38980361)
1. Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all. Prattes J; Giacobbe DR; Bassetti M; Gangneux JP; Hoenigl M; Intensive Care Med; 2024 Aug; 50(8):1375-1377. PubMed ID: 38980361 [No Abstract] [Full Text] [Related]
14. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit. Fumarola B; Signorini L; Lorenzotti S; Lanza P; Saccani B; Van Hauwermeiren E; Mulè A; Piva S; Rota M; Zuccalà F; Rasulo FA; Filippini M; Bertazzoli A; Del Fabro G; Matteelli A Infection; 2024 Aug; 52(4):1459-1468. PubMed ID: 38530518 [TBL] [Abstract][Full Text] [Related]
15. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Armstrong-James D; Youngs J; Bicanic T; Abdolrasouli A; Denning DW; Johnson E; Mehra V; Pagliuca T; Patel B; Rhodes J; Schelenz S; Shah A; van de Veerdonk FL; Verweij PE; White PL; Fisher MC Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703771 [TBL] [Abstract][Full Text] [Related]
16. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis. Le Daré B; Boglione-Kerrien C; Reizine F; Gangneux JP; Bacle A Crit Care; 2021 Apr; 25(1):152. PubMed ID: 33879175 [No Abstract] [Full Text] [Related]
17. [What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis]. Scharf C; Zoller M; Liebchen U Anaesthesist; 2021 May; 70(5):432-433. PubMed ID: 33635372 [No Abstract] [Full Text] [Related]
18. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Salmanton-García J; Sprute R; Stemler J; Bartoletti M; Dupont D; Valerio M; Garcia-Vidal C; Falces-Romero I; Machado M; de la Villa S; Schroeder M; Hoyo I; Hanses F; Ferreira-Paim K; Giacobbe DR; Meis JF; Gangneux JP; Rodríguez-Guardado A; Antinori S; Sal E; Malaj X; Seidel D; Cornely OA; Koehler P; Emerg Infect Dis; 2021; 27(4):1077-1086. PubMed ID: 33539721 [TBL] [Abstract][Full Text] [Related]
19. Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis. Soriano MC; Narváez-Chávez G; López-Olivencia M; Fortún J; de Pablo R Intensive Care Med; 2022 Mar; 48(3):360-361. PubMed ID: 34940907 [No Abstract] [Full Text] [Related]
20. Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels. Bakir Ekinci P; Kara E; Er AG; Inkaya AC; Demirkan K; Uzun O Br J Clin Pharmacol; 2022 Mar; 88(3):1387-1391. PubMed ID: 34174111 [No Abstract] [Full Text] [Related] [Next] [New Search]